Cited by 41Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchNeurological Disease Mechanisms and Treatments

Early-life stress leads to impaired spatial learning and memory in middle-aged ApoE4-TR mice

Open access
Lin, Lan-yan, Zhang, Jing, Dai, Xiao-man, Xiao, Nai-an, Wu, Xi-lin, Wei, Zhen, Fang, Wen-ting, Zhu, Yuan-gui +1 more·2016·Molecular Neurodegeneration

Abstract

BACKGROUND: Apolipoprotein E (ApoE) is a major lipid carrier that supports lipid transport and injury repair in the brain. The APOE ε4 allele is associated with depression, mild cognitive impairment (MCI) and dementia; however, the precise molecular mechanism through which ApoE4 influences the risk of disease development remains unknown. To address this gap in knowledge, we investigated the potential effects of chronic unpredictable mild stress (CUMS) on ApoE3 and ApoE4 target replacement (ApoE3-TR and ApoE4-TR) mice. RESULTS: All ApoE-TR mice exposed to CUMS at 3 months old recovered from a depression-like state by the age of 12 months. Of note, ApoE4-TR mice, unlike age-matched ApoE3-TR mice, displayed impaired spatial cognitive abilities, loss of GABAergic neurons, decreased expression of Reelin, PSD95, SYN and Fyn, and reduced phosphorylation of NMDAR2B and CREB. CONCLUSION: These results suggest that early-life stress may mediate cognitive impairment in middle-age ApoE4-TR mice through sustained reduction of GABAergic neurons and Reelin expression, which might further diminish the activation of the Fyn/NMDAR2B signaling pathway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-016-0107-2

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An early-life depression event elevates the subsequent AD risk.

    “An early-life depression event elevates the subsequent AD risk [34].”

    From APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline (2021) · cites this paper as [34]

    The Background (page unavailable) says early-life depressive symptoms may increase the risk of cognitive impairment in old age. It does not establish that an early-life depressive episode increases subsequent Alzheimer’s disease risk; the AD-risk finding it discusses concerns late-onset depression together with APOE4. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Compared with apoE3 at 3 months of age, apoE4 did not aggravate depression-like behaviors under chronic unpredictable mild stress (CUMS).

    “Our previous research has shown that compared with apoE3 at the age of 3 months, apoE4 did not aggravate the depression-like behaviors under chronic unpredictable mild stress (CUMS) [34].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 51

  1. [1]Mahley RW Weisgraber KH Huang Y Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer’s disease Proc Natl Acad Sci U S A 2006 103 5644 51 10.1073/pnas.0600549103 16567625 PMC1414631 · DOI · Paper page
  2. [2]Huang Y Liu XQ Wyss-Coray T Brecht WJ Sanan DA Mahley RW Apolipoprotein E fragments present in Alzheimer’s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons Proc Natl Acad Sci U S A 2001 98 8838 43 10.1073/pnas.151254698 11447277 PMC37522 · DOI · Paper page
  3. [3]Huang Y Apolipoprotein E, and Alzheimer disease Neurology 2006 66 S79 85 10.1212/01.wnl.0000192102.41141.9e 16432152 · DOI
  4. [4]Farrer LA Cupples LA Haines JL Hyman B Kukull WA Mayeux R Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium JAMA 1997 278 1349 56 10.1001/jama.1997.03550160069041 9343467 · DOI · Paper page
  5. [5]Corder EH Saunders AM Strittmatter WJ Schmechel DE Gaskell PC Small GW Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families Science 1993 261 921 3 10.1126/science.8346443 8346443 · DOI · Paper page
  6. [6]Saunders AM Strittmatter WJ Schmechel D George-Hyslop PH Pericak-Vance MA Joo SH Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease Neurology 1993 43 1467 72 10.1212/WNL.43.8.1467 8350998 · DOI · Paper page
  7. [7]Stewart R Russ C Richards M Brayne C Lovestone S Mann A Depression, APOE genotype and subjective memory impairment: a cross-sectional study in an African-Caribbean population Psychol Med 2001 31 431 40 11305851
  8. [8]Rapp MA Schnaider-Beeri M Grossman HT Sano M Perl DP Purohit DP Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression Arch Gen Psychiatry 2006 63 161 7 10.1001/archpsyc.63.2.161 16461859 · DOI
  9. [9]Jorm AF van Duijn CM Chandra V Fratiglioni L Graves AB Heyman A Psychiatric history and related exposures as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group Int J Epidemiol 1991 20 Suppl 2 S43 7 10.1093/ije/20.Supplement_2.S43 1917269 · DOI
  10. [10]Kokmen E Beard CM Chandra V Offord KP Schoenberg BS Ballard DJ Clinical risk factors for Alzheimer’s disease: a population-based case-control study Neurology 1991 41 1393 7 10.1212/WNL.41.9.1393 1891088 · DOI
  11. [11]Park S Nam YY Sim Y Hong JP Interactions between the apolipoprotein E epsilon4 allele status and adverse childhood experiences on depressive symptoms in older adults Eur J Psychotraumatol 2015 6 25178 10.3402/ejpt.v6.25178 25630472 PMC4309830 · DOI
  12. [12]Kim DH Payne ME Levy RM MacFall JR Steffens DC APOE genotype and hippocampal volume change in geriatric depression Biol Psychiatry 2002 51 426 9 10.1016/S0006-3223(01)01272-0 11904138 · DOI
  13. [13]Steffens DC Plassman BL Helms MJ Welsh-Bohmer KA Saunders AM Breitner JC A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer’s disease Biol Psychiatry 1997 41 851 6 10.1016/S0006-3223(96)00247-8 9099411 · DOI
  14. [15]Kim JM Stewart R Kim SY Kim SW Bae KY Yang SJ Synergistic associations of depression and apolipoprotein E genotype with incidence of dementia Int J Geriatr Psychiatry 2011 26 893 8 10.1002/gps.2621 21845591 · DOI
  15. [16]Rajan KB Wilson RS Skarupski KA de Leon CF M Evans DA Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline Psychosom Med 2014 76 101 8 10.1097/PSY.0000000000000029 24434953 PMC4142223 · DOI
  16. [17]Rajkowska G O’Dwyer G Teleki Z Stockmeier CA Miguel-Hidalgo JJ GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression Neuropsychopharmacology 2007 32 471 82 10.1038/sj.npp.1301234 17063153 PMC2771699 · DOI · Paper page
  17. [18]Alcantara S Ruiz M D’Arcangelo G Ezan F de Lecea L Curran T Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse J Neurosci 1998 18 7779 99 9742148 PMC6792998
  18. [19]D’Arcangelo G Homayouni R Keshvara L Rice DS Sheldon M Curran T Reelin is a ligand for lipoprotein receptors Neuron 1999 24 471 9 10.1016/S0896-6273(00)80860-0 10571240 · DOI · Paper page
  19. [20]Herz J Chen Y Reelin, lipoprotein receptors and synaptic plasticity Nat Rev Neurosci 2006 7 850 9 10.1038/nrn2009 17053810 · DOI · Paper page
  20. [21]Niu S Renfro A Quattrocchi CC Sheldon M D’Arcangelo G Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway Neuron 2004 41 71 84 10.1016/S0896-6273(03)00819-5 14715136 · DOI · Paper page
  21. [22]Niu S Yabut O D’Arcangelo G The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons J Neurosci 2008 28 10339 48 10.1523/JNEUROSCI.1917-08.2008 18842893 PMC2572775 · DOI · Paper page
  22. [23]Fatemi SH Reelin, a marker of stress resilience in depression and psychosis Neuropsychopharmacology 2011 36 2371 2 10.1038/npp.2011.169 21997708 PMC3194087 · DOI
  23. [24]Impagnatiello F Guidotti AR Pesold C Dwivedi Y Caruncho H Pisu MG A decrease of reelin expression as a putative vulnerability factor in schizophrenia Proc Natl Acad Sci U S A 1998 95 15718 23 10.1073/pnas.95.26.15718 9861036 PMC28110 · DOI
  24. [25]Teixeira CM Martin ED Sahun I Masachs N Pujadas L Corvelo A Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder Neuropsychopharmacology 2011 36 2395 405 10.1038/npp.2011.153 21814183 PMC3194085 · DOI
  25. [27]Knouff C Hinsdale ME Mezdour H Altenburg MK Watanabe M Quarfordt SH Apo E structure determines VLDL clearance and atherosclerosis risk in mice J Clin Invest 1999 103 1579 86 10.1172/JCI6172 10359567 PMC408371 · DOI · Paper page
  26. [28]Moreau JL Scherschlicht R Jenck F Martin JR Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment Behav Pharmacol 1995 6 682 7 10.1097/00008877-199511000-00003 11224370 · DOI
  27. [29]Forbes NF Stewart CA Matthews K Reid IC Chronic mild stress and sucrose consumption: validity as a model of depression Physiol Behav 1996 60 1481 4 10.1016/S0031-9384(96)00305-8 8946494 · DOI
  28. [30]Pothion S Bizot JC Trovero F Belzung C Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress Behav Brain Res 2004 155 135 46 10.1016/j.bbr.2004.04.008 15325787 · DOI
  29. [31]Pellow S Chopin P File SE Briley M Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 1985 14 149 67 10.1016/0165-0270(85)90031-7 2864480 · DOI · Paper page
  30. [32]Rodgers RJ Cole JC Aboualfa K Stephenson LH Ethopharmacological analysis of the effects of putative ‘anxiogenic’ agents in the mouse elevated plus-maze Pharmacol Biochem Behav 1995 52 805 13 10.1016/0091-3057(95)00190-8 8587923 · DOI
  31. [33]Heimrich B Claus H Schwegler H Haas HL Hippocampal mossy fiber distribution and long-term potentiation in two inbred mouse strains Brain Res 1989 490 404 6 10.1016/0006-8993(89)90262-X 2765874 · DOI
  32. [34]Crowley JJ Jones MD O’Leary OF Lucki I Automated tests for measuring the effects of antidepressants in mice Pharmacol Biochem Behav 2004 78 269 74 10.1016/j.pbb.2004.03.014 15219767 · DOI
  33. [35]Morris R Developments of a water-maze procedure for studying spatial learning in the rat J Neurosci Methods 1984 11 47 60 10.1016/0165-0270(84)90007-4 6471907 · DOI · Paper page
  34. [36]Vorhees CV Williams MT Morris water maze: procedures for assessing spatial and related forms of learning and memory Nat Protoc 2006 1 848 58 10.1038/nprot.2006.116 17406317 PMC2895266 · DOI · Paper page
  35. [37]Kalueff AV Nutt DJ Role of GABA in anxiety and depression Depress Anxiety 2007 24 495 517 10.1002/da.20262 17117412 · DOI
  36. [39]Veeraiah P Noronha JM Maitra S Bagga P Khandelwal N Chakravarty S Dysfunctional glutamatergic and gamma-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression Biol Psychiatry 2014 76 231 8 10.1016/j.biopsych.2013.09.024 24239130 · DOI
  37. [40]D’Arcangelo G Apoer2: a reelin receptor to remember Neuron 2005 47 471 3 10.1016/j.neuron.2005.08.001 16102527 · DOI · Paper page
  38. [41]Gucuyener DO Yenilmez C Ayranci U Ozdemir F Uzuner N Ozkan S An analysis of changes in cerebral blood flood velocities in depressive pseudo-dementia and Alzheimer disease patients Neurologist 2010 16 358 63 10.1097/NRL.0b013e3181a2eace 21150383 · DOI
  39. [42]Banga A Gyurmey T Matuskey D Connor DF Kaplan RF Steffens DC Late-life onset bipolar disorder presenting as a case of pseudo-dementia: a case discussion and review of literature Yale J Biol Med 2013 86 235 44 23766743 PMC3670442
  40. [43]Siegel JA Haley GE Raber J Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice Neurobiol Aging 2012 33 345 58 10.1016/j.neurobiolaging.2010.03.002 20400205 PMC2935518 · DOI
  41. [44]Rijpma A Jansen D Arnoldussen IAC Fang XT Wiesmann M Mutsaers MPC Sex differences in presynaptic density and neurogenesis in middle-aged ApoE4 and ApoE knockout mice J Neurodegener Dis 2013 2013 1 9 10.1155/2013/531326 PMC4437335 26316992 · DOI
  42. [45]Sachs-Ericsson N Joiner T Plant EA Blazer DG The influence of depression on cognitive decline in community-dwelling elderly persons Am J Geriatr Psychiatry 2005 13 402 8 10.1097/00019442-200505000-00009 15879589 · DOI
  43. [46]Corsentino EA Sawyer K Sachs-Ericsson N Blazer DG Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults Am J Geriatr Psychiatry 2009 17 155 65 10.1097/JGP.0b013e31818f3a6b 19155747 PMC2744964 · DOI
  44. [47]Benes FM Berretta S GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder Neuropsychopharmacology 2001 25 1 27 10.1016/S0893-133X(01)00225-1 11377916 · DOI · Paper page
  45. [48]Guidotti A Auta J Davis JM Di-Giorgi-Gerevini V Dwivedi Y Grayson DR Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study Arch Gen Psychiatry 2000 57 1061 9 10.1001/archpsyc.57.11.1061 11074872 · DOI
  46. [49]McColl BW McGregor AL Wong A Harris JD Amalfitano A Magnoni S APOE epsilon3 gene transfer attenuates brain damage after experimental stroke J Cereb Blood Flow Metab 2007 27 477 87 10.1038/sj.jcbfm.9600361 16804548 · DOI
  47. [50]Knoferle J Yoon SY Walker D Leung L Gillespie AK Tong LM Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice J Neurosci 2014 34 14069 78 10.1523/JNEUROSCI.2281-14.2014 25319703 PMC4198545 · DOI · Paper page
  48. [54]Tong LM Yoon SY Andrews-Zwilling Y Yang A Lin V Lei H Enhancing GABA signaling during middle adulthood prevents age-dependent GABAergic interneuron decline and learning and memory deficits in ApoE4 mice J Neurosci 2016 36 2316 22 10.1523/JNEUROSCI.3815-15.2016 26888940 PMC4756160 · DOI · Paper page
  49. [55]Tong LM Djukic B Arnold C Gillespie AK Yoon SY Wang MM Inhibitory interneuron progenitor transplantation restores normal learning and memory in ApoE4 knock-in mice without or with Abeta accumulation J Neurosci 2014 34 9506 15 10.1523/JNEUROSCI.0693-14.2014 25031394 PMC4099537 · DOI · Paper page
  50. [56]Fatemi SH Reelin glycoprotein: structure, biology and roles in health and disease Mol Psychiatry 2005 10 251 7 10.1038/sj.mp.4001613 15583703 · DOI · Paper page
  51. [57]Liu DS Pan XD Zhang J Shen H Collins NC Cole AM APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice Mol Neurodegener 2015 10 7 10.1186/s13024-015-0002-2 25871877 PMC4391134 · DOI · Paper page

Cited by

Sorted by citations

Authors
Lin, L.-Y., Zhang, J., Dai, X.-M., Xiao, N.-A., Wu, X.-L., Wei, Z., Fang, W.-T., Zhu, Y.-G., & Chen, X.-C.
Affiliations
Fujian Medical University (CN)
Venue
Molecular Neurodegeneration
Published
2016-07-12
Volume
11
Issue
1
Pages
51-51
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2468956168
Cited by
41
References
6
Citations by year
2026: 7 · 2025: 8 · 2024: 2 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 3
FWCI
1.83
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (91232709, 81171216, 81161120496, 81401149)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
early life stress, chronic unpredictable mild stress, APOE ε4, APOE3, spatial learning and memory, cognitive impairment, depression-like behavior, GABAergic neurons, reelin, PSD-95, synaptophysin, Fyn, NMDAR2B, CREB, middle age (human life stage)
MeSH terms
Reelin Protein, Aging, Animals, Dementia, Humans, Male, Memory, Mice, Transgenic, Neurons, Stress, Psychological, Mice, Apolipoprotein E4, Spatial Learning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review